Algo version: 0.98b
China National Medicines is listed at the SHH Exchange
China National Medicines [600511.SS]
SHH Sector: Healthcare Industry:Drug Manufacturers—Specialty & Generic

Is China National Medicines stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, China National Medicines pays dividends. Last time was Thursday 13th of June 2024 where the investors holding the stock on Thursday 13th of June 2024 were paid CNY0.854 per share. Over the last 22 times between 2003 and 2024, China National Medicines has paid CNY6.914 with an average of CNY0.31 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for China National Medicines 10 years ago, but if you had invested on Monday 21st of October 2019 when the price was CNY27.98, you would have made a profit of CNY4.99 per share or 17.83%

Yes, the average daily trading liquidity for China National Medicines is CNY6.35 million. You should therefore be able to get in and out of your positions relatively fast.

China National Medicines has little of the business financed by loans. This puts the company at lower risk in periods of high inflation where borrowing costs usually go up. With a high cash flow to debt ratio of 0.56, the company's ability to pay off the debt is good. The company has a very low net profit margin of 4.30%, which is challenging.

We have calculated the inflation risk for China National Medicines to be low [0.2 of 1]

US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.09 and is down -0.37 over the last 30 days.